Observational studyJournal of autism and developmental disorders2020
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
Observational study in Journal of autism and developmental disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review.Health technology assessment (Winchester, England) · 2024Pooled it
- Perspectives of South Korean Parents Toward Psychotropic Medication Use Among Autistic Individuals.Journal of autism and developmental disorders · 2026Article
- Personality disorder diagnoses in UK Autistic people: Evidence from a matched cohort study.Autism : the international journal of research and practice · 2026Article
- Patterns of Psychotropic Prescribing Practices in Autistic Children and Adolescents: An Australian Perspective of Two Cohorts Five Years Apart.Child psychiatry and human development · 2026Article
- Selective Serotonin Reuptake Inhibitors for Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.Clinical medicine insights. Pediatrics · 2026Review
- Utilization of psychotropic medications in individuals with autism spectrum disorder.BMC psychiatry · 2025Article
- Clinical determinants of psychiatric care in genetic neurodevelopmental disorders: a cross-sectional analysis.Journal of neurodevelopmental disorders · 2025Article
- Examination of Psychotropic Medication Use Following Outpatient Behavioral Assessment and Treatment.Brain sciences · 2025Article
- Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid.Journal of autism and developmental disorders · 2025Article
- Diagnosis of common health conditions among autistic adults in the UK: evidence from a matched cohort study.The Lancet regional health. Europe · 2024Article
- Gestational hypothyroxinemia induces ASD-like phenotypes in behavior, proinflammatory markers, and glutamatergic protein expression in mouse offspring of both sexes.Frontiers in endocrinology · 2024Article
- Estimating life expectancy and years of life lost for autistic people in the UK: a matched cohort study.The Lancet regional health. Europe · 2024Article
- Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.Autism : the international journal of research and practice · 2023Article
- Antipsychotic Medication and Risk of Incident Seizure in People with Autism Spectrum Disorder: Analyses with Cohort and Within Individual Study Designs.Journal of autism and developmental disorders · 2022Article
- Review
- Understanding the Diversity of Pharmacotherapeutic Management of ADHD With Co-occurring Autism: An Australian Cross-Sectional Survey.Frontiers in psychiatry · 2022Article
- Review
- Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model.Brain sciences · 2020Article
- Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK.BMJ open · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a lifelong disorder. In the UK, risperidone is the only psychotropic medication approved for the management of the behavioural symptoms that may accompany autism. This is a population-based study aimed to provide an evaluation of the changing trend in the incidence and prevalence of ASD and to analyse the pattern of psychotropic medication prescribing in the UK. 20,194 patients with ASD were identified. The prevalence increased 3.3-fold from 0.109 per 100 persons in 2009 to 0.355 per 100 persons in 2016. Approximately one-third of the identified cohort was prescribed at least one psychotropic medication. Although the medications approved to manage the symptoms of ASD are limited, the prescribing of such medications is increasing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.